FBR Capital Initiates Regulus Therapeutics With Outperform By: Benzinga via Benzinga April 21, 2015 at 08:23 AM EDT Analysts at FBR Capital initiated coverage on Regulus Therapeutics Inc (NASDAQ: RGLS) with a Outperform rating. The target price for ... Read More >> Related Stocks: Regulus Therapeutics